Gary Skarja
Directeur Technique/Scientifique/R&D chez NATRIX Separations, Inc.
Profil
Gary Skarja is currently the Director of Research & Development at Natrix Separations, Inc. He previously worked as the Director of Biomaterials & Devices Division at Centre For Commercialization of Regenerative Medicine and Regenerative Medicine Solutions LLC.
He also served as the Chief Operating Officer & Vice President at Rimon Therapeutics Ltd.
Skarja holds a doctorate degree from the University of Toronto and undergraduate and graduate degrees from McMaster University.
Postes actifs de Gary Skarja
| Sociétés | Poste | Début |
|---|---|---|
NATRIX Separations, Inc.
 NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Directeur Technique/Scientifique/R&D | 01/12/2012 |
Anciens postes connus de Gary Skarja
| Sociétés | Poste | Fin |
|---|---|---|
Rimon Therapeutics Ltd.
 Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Directeur des opérations | - |
Regenerative Medicine Solutions LLC
 Regenerative Medicine Solutions LLC BiotechnologyHealth Technology Regenerative Medicine Solutions LLC provides regenerative technologies for the treatment of an array of debilitating conditions. It also provides stem cell treatments, gene therapy, platelet-rich plasma, natural growth factors and other innovative regenerative medical technologies, for the treatment of an array of debilitating medical conditions. The company was founded in 2012 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Formation de Gary Skarja
| University of Toronto | Doctorate Degree |
| McMaster University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
Rimon Therapeutics Ltd.
Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Health Technology |
Regenerative Medicine Solutions LLC
Regenerative Medicine Solutions LLC BiotechnologyHealth Technology Regenerative Medicine Solutions LLC provides regenerative technologies for the treatment of an array of debilitating conditions. It also provides stem cell treatments, gene therapy, platelet-rich plasma, natural growth factors and other innovative regenerative medical technologies, for the treatment of an array of debilitating medical conditions. The company was founded in 2012 and is headquartered in Tampa, FL. | Health Technology |